USD 1.48 Billion
Report ID:
SQMIG35A2494 |
Region:
Global |
Published Date: March, 2024
Pages:
219
|
Tables:
95 |
Figures:
76
Global Tumor Ablation Market size was valued at USD 1.48 Billion in 2022 and is poised to grow from USD 1.68 Billion in 2023 to USD 4.63 Billion by 2031, by rising at a CAGR 13.5% during the forecast period (2024-2031).
The increasing prevalence of cancer & the strong desire for safer therapeutic choices are important factors driving market expansion. According to the WHO, by 2030, 10-11 million instances of cancer are expected to be diagnosed globally each year. The number of new cases of cancer in low-income nations is anticipated to rise by more than 80%, compared to half the pace in high-income countries (40%). Lucrative potential for expansion in currently existing therapeutic choices, as well as a strong desire for minimally & non-invasive therapies, are projected to drive the market in the future years.
The growing preference of surgeons and patients for minimally invasive procedures due to benefits such as faster recovery, patient comfort, the shorter turnaround time is likely to boost demand for advanced tumor ablation methods over the forecast period. When opposed to conventional therapy, advanced tumor ablation procedures are often conducted on an outpatient basis & lack any hospital admission, considerably lowering total healthcare costs. Ablative operations are the primary treatment for tiny tumors. As a result, its procedural number is indirectly affected by yearly cancer detection rates. The market was considerably impacted in 2020 as the number of cases of cancer that were newly diagnosed decreased significantly during COVID due to less screening measures done by relevant authorities.
According to a survey by Our World in Data (OWD), an initiative of Global Change Data Lab, more than 70% of cancer diagnoses occurred in persons over the age of 50. The number is likely to rise in lockstep with the growing senior population. As the body's basic systems deteriorate with age, the aging population is the primary target group for noninvasive ablation procedures. As a result, the rising aging population is predicted to drive up demand for tumor ablation procedures over the projection period.
The drivers motivating market participants to consistently upgrade and launch advanced products are technological advancements to improve accuracy, mobility, and cost-effectiveness. These technological developments include image-guided devices, HIFU, and cryoablation. One of the upcoming techniques that is expected to play a big role in market expansion is the use of the cooled radiofrequency degeneration technique with externally chilled radiofrequency probes to increase the size of the lesion. This procedure allows for total degeneration of the sacroiliac joint, resulting in pain relief.
Global Market Size
USD 1.48 Billion
Largest Segment
Radiofrequency Tumor
Fastest Growth
Radiofrequency Tumor
Growth Rate
al Tumor Ablation Market size was valued at USD 1.48 Billion in 2022 and is poised to grow from USD 1.68 Billion in 2023 to USD 4.63 Billion by 2031, by rising at a CAGR 13.5% CAGR
To get more reports on the above market click here to Buy The Report
The global tumor ablation market is segmented on the basis of technology, application, end user, and region. Based on technology, the market is segmented into radiofrequency ablation, microwave ablation, cryoablation, irreversible electroporation ablation, and other ablation technologies. Based on treatment, the market is segmented into surgical ablation, laparoscopic ablation, and percutaneous ablation. Based on application, the market is segmented into kidney cancer, liver cancer, breast cancer, lung cancer, prostate cancer, and other cancer. Based on region the global Tumor Ablation Market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.
Global Tumor Ablation Market Analysis by Technology
The radiofrequency tumor ablation technology sector held the highest revenue share of more than 35.0%. The advantage of specificity and efficacy in solid tumor ablation treatments in the kidneys and liver can be attributed to its dominance. Furthermore, with the use of several electrodes put at different places, radiofrequency ablation may be utilized to treat multiple tumors at the same time, boosting procedural efficiency. This is predicted to increase the rate of adoption of sophisticated tumor ablation procedures.
The microwave ablation method is predicted to have a success rate of more than 85% in removing tiny liver tumors. According to the NCBI analysis, tumor recurrence ranged from 30% to 70% in patients who chose surgical resection. Tumor recurrence, on the other hand, is extremely low (0.7-8%) in cases of radiation therapy for comparable tumors. During the forecast period, the advantages of rf approaches for successfully treating tumors in their early stages are projected to drive the market.
The microwave ablation technology is expected to expand in value during the projected period. Unlike a radiofrequency ablation device, the energy of a microwave (MW) ablation device propagates an electromagnetic field. This facilitates the use of microwave excision technology in tissues with poor electrical conductivity, such as bones & lungs. This approach has several advantages, including a greater tumor ablation quantity, consistency in temperatures, low ablation discomfort, and optimal warming of the cystic mass. These advantages are expected to help this segment flourish. Furthermore, the segment is likely to be driven by shorter procedure times (5-10 minutes), higher efficacy with fewer problems, and shorter hospital stays.
Global Tumor Ablation Market Analysis by Application
Liver cancer dominated the market in 2022, accounting for more than 20% of total revenue. This is because bile duct cancer & primary liver cancer are becoming more common. There are various applications in the market, including cancer of the kidneys, liver cancer, cancer of the breast, lung cancer, cancer of the prostate, and others. Other types of cancer include metastases to the bone and ENT carcinoma. The availability of advanced technology, combined with increased cancer prevalence, is likely to fuel market growth.
Renal or kidney cancer is expected to develop rapidly during the prediction period. Renal tumors can be effectively treated using radiofrequency & microwave ablation techniques. Patients with solitary kidneys, tumors smaller than 4cm in size, and a sluggish post-surgical recovery period are candidates for kidney tumor ablation. Furthermore, as medical imaging becomes more widely used, the number of instances diagnosed is likely to rise, pushing demand for therapies during the projection period.
To get detailed analysis on other segments, Request For Free Sample Report
North America led the global market, capturing more than 30.0% of total sales. Government support for great healthcare, high buying power parity, reimbursement availability, and the rising prevalence of cancer are all major reasons driving this region's rise. In the United States, for example, the Patient Protection and Affordable Care Act (PPACA) improves the quality and affordability of health care via health coverage laws that minimize healthcare costs for individuals and the government. Furthermore, the precision medicine effort is a crucial growth factor in developing personalized solutions for diseases with distinct characteristics. As a result, such government activities are expected to strengthen the whole healthcare system, hence stimulating market growth.
Asia Pacific is anticipated to grow at the fastest rate over the forecast duration. The growing presence of large healthcare providers in rapidly emerging countries like China and India opens up new commercial opportunities. Furthermore, with government assistance, healthcare utilization is expanding across Asia Pacific. For example, the Health Minister Cancer Patient Fund (HMCPF) scheme of the Indian government provides financial assistance to destitute cancer patients. Throughout the forecast period, this is projected to fuel demand for tumor removal devices.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Global Tumor Ablation Market Drivers
Increasing Incidence of Cancer
Global Tumor Ablation Market Restraints
High Cost of Ablation Procedures
Request Free Customization of this report to help us to meet your business objectives.
Key companies are increasing their expenditure on R&D to produce minimally invasive and new tumor ablative therapies in order to gain a huge market share. For example, Boston Scientific Corporation got Health Canada certification in 2021 for its advanced freezing system, ICEfxTM. The device has a lower footprint, is portable, and offers a potent alternative to current cryoablation systems.
In order to maintain their market position, industry participants have implemented a variety of strategic activities such as new product launches, alliances, mergers, and acquisitions.
Top Player’s Company Profiles in Global Tumor Ablation Market
Global Tumor Ablation Market Recent Developments
Butterfly Network introduced a tumor ablation gadget in February 2024. AI and 3D imagery have been used in the development of a novel portable ultrasound device. The system is a point-of-care gadget known as iQ3TM, and it performs optimal organ scanning. It offers 46 broad angle ultrasonic slices at the same time.
The CE (Conformité Européenne) Mark was granted to Medtronic Public Limited Company in August 2023 for its closed-loop rechargeable spinal cord stimulator (SCS), Inceptiv. It is the first Medtronic SCS device with a closed-loop function that senses individual biological signals and modifies stimulation as needed in real time to keep therapy in sync with everyday activities.
Compal Electronics, a Taiwanese electronics manufacturer, debuted a new radiofrequency ablation (RFA) device in April 2023. It is intended for use in percutaneous and intraoperative soft tissue coagulation and ablation procedures. This covers the ablation of non-resectable liver lesions, either fully or partially. Furthermore, Compal Electronics unveiled a bi-level ventilator designed to treat respiratory insufficiency brought on by central and/or mixed apneas and chronic obstructive pulmonary disease (COPD).
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates and Analyzes the Data collected by means of Primary Exploratory Research backed by the robust Secondary Desk research.
According to our tumor ablation market analysis, the increased demand for visually pleasing multipurpose tumor ablations that compliment other plumbing fixtures is driving the market. The demand for automated Tumor Ablations is increasing due to their convenience, efficiency, and touchless operation. These dispensers help minimize the spread of germs, reduce product waste, and offer a hygienic hand washing experience, particularly in public restrooms, healthcare facilities, and food service establishments.
Report Metric | Details |
---|---|
Market size value in 2023 | USD 1.48 Billion |
Market size value in 2031 | USD 4.63 Billion |
Growth Rate | al Tumor Ablation Market size was valued at USD 1.48 Billion in 2022 and is poised to grow from USD 1.68 Billion in 2023 to USD 4.63 Billion by 2031, by rising at a CAGR 13.5% |
Forecast period | 2024-2031 |
Forecast Unit (Value) | USD Billion |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
For the Global Tumor Ablation Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Global Tumor Ablation Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Global Tumor Ablation Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Global Tumor Ablation Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Product ID: SQMIG35A2494